Compumedics Limited (ASX:CMP)

Compumedics Statistics

Total Valuation

Compumedics has a market cap or net worth of AUD 70.92 million. The enterprise value is 82.10 million.

Market Cap	70.92M
Enterprise Value	82.10M

Important Dates

The next estimated earnings date is Sunday, February 22, 2026.

Earnings Date	Feb 22, 2026
Ex-Dividend Date	n/a

Share Statistics

Compumedics has 199.76 million shares outstanding. The number of shares has increased by 6.26% in one year.

Current Share Class	199.76M
Shares Outstanding	199.76M
Shares Change (YoY)	+6.26%
Shares Change (QoQ)	+2.79%
Owned by Insiders (%)	53.77%
Owned by Institutions (%)	2.95%
Float	71.99M

Valuation Ratios

PE Ratio	n/a
Forward PE	23.67
PS Ratio	1.39
PB Ratio	3.27
P/TBV Ratio	3.27
P/FCF Ratio	304.36
P/OCF Ratio	158.65
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 34.98, with an EV/FCF ratio of 352.38.

EV / Earnings	-64.75
EV / Sales	1.61
EV / EBITDA	34.98
EV / EBIT	91.63
EV / FCF	352.38

Financial Position

The company has a current ratio of 1.11, with a Debt / Equity ratio of 0.64.

Current Ratio	1.11
Quick Ratio	0.65
Debt / Equity	0.64
Debt / EBITDA	5.91
Debt / FCF	59.57
Interest Coverage	0.70

Financial Efficiency

Return on equity (ROE) is -6.35% and return on invested capital (ROIC) is 2.72%.

Return on Equity (ROE)	-6.35%
Return on Assets (ROA)	1.18%
Return on Invested Capital (ROIC)	2.72%
Return on Capital Employed (ROCE)	3.98%
Weighted Average Cost of Capital (WACC)	6.05%
Revenue Per Employee	291,657
Profits Per Employee	-7,246
Employee Count	175
Asset Turnover	1.08
Inventory Turnover	1.64

Taxes

In the past 12 months, Compumedics has paid 857,000 in taxes.

Income Tax	857,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +33.93% in the last 52 weeks. The beta is 0.28, so Compumedics's price volatility has been lower than the market average.

Beta (5Y)	0.28
52-Week Price Change	+33.93%
50-Day Moving Average	0.36
200-Day Moving Average	0.32
Relative Strength Index (RSI)	50.33
Average Volume (20 Days)	78,986

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Compumedics had revenue of AUD 51.04 million and -1.27 million in losses. Loss per share was -0.01.

Revenue	51.04M
Gross Profit	28.13M
Operating Income	896,000
Pretax Income	-411,000
Net Income	-1.27M
EBITDA	1.40M
EBIT	896,000
Loss Per Share	-0.01

Balance Sheet

The company has 2.69 million in cash and 13.88 million in debt, with a net cash position of -11.19 million or -0.06 per share.

Cash & Cash Equivalents	2.69M
Total Debt	13.88M
Net Cash	-11.19M
Net Cash Per Share	-0.06
Equity (Book Value)	21.71M
Book Value Per Share	0.11
Working Capital	3.37M

Cash Flow

In the last 12 months, operating cash flow was 447,000 and capital expenditures -214,000, giving a free cash flow of 233,000.

Operating Cash Flow	447,000
Capital Expenditures	-214,000
Free Cash Flow	233,000
FCF Per Share	0.00

Margins

Gross margin is 55.11%, with operating and profit margins of 1.76% and -2.48%.

Gross Margin	55.11%
Operating Margin	1.76%
Pretax Margin	-0.81%
Profit Margin	-2.48%
EBITDA Margin	2.74%
EBIT Margin	1.76%
FCF Margin	0.46%

Dividends & Yields

Compumedics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.26%
Shareholder Yield	-6.26%
Earnings Yield	-1.79%
FCF Yield	0.33%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Compumedics has an Altman Z-Score of 1.6 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.6
Piotroski F-Score	5